Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5024,219.050.14%H 24,313 · L 24,144.3|Sensex77,369.110.22%H 77,789.4 · L 77,201.66|Bank Nifty57,525.950.41%H 57,873.75 · L 57,245.95|USD / INR₹95.730.05%H ₹95.75 · L ₹95.63|Gold Intl (10g)₹1,45,340.770.88%H ₹1,45,848.63 · L ₹1,43,180.05|Silver Intl (1kg)₹2,12,578.580.67%H ₹2,15,225.61 · L ₹2,10,593.3|Crude WTI₹8,175.771.91%H ₹8,287.78 · L ₹8,113.54|Bitcoin₹75,34,8581.55%H ₹75,93,260.38 · L ₹74,76,455.62|Ethereum₹2,38,8751.36%H ₹2,40,499.63 · L ₹2,37,250.37|Nifty 5024,219.050.14%H 24,313 · L 24,144.3|Sensex77,369.110.22%H 77,789.4 · L 77,201.66|Bank Nifty57,525.950.41%H 57,873.75 · L 57,245.95|USD / INR₹95.730.05%H ₹95.75 · L ₹95.63|Gold Intl (10g)₹1,45,340.770.88%H ₹1,45,848.63 · L ₹1,43,180.05|Silver Intl (1kg)₹2,12,578.580.67%H ₹2,15,225.61 · L ₹2,10,593.3|Crude WTI₹8,175.771.91%H ₹8,287.78 · L ₹8,113.54|Bitcoin₹75,34,8581.55%H ₹75,93,260.38 · L ₹74,76,455.62|Ethereum₹2,38,8751.36%H ₹2,40,499.63 · L ₹2,37,250.37|
0%
IPOs

OpenAI Eyes IPO by 2027, CFO Confirms

Arth Vani DeskPublished: 1 min read
OpenAI Eyes IPO by 2027, CFO Confirms

Source: Yahoo Finance (Global)

Arth Insight · What this means for your wallet

Immediate action
Keep an eye on further announcements from OpenAI regarding its IPO plans.
  • OpenAI is planning to go public with an IPO, potentially by 2027.
  • The company's CFO has confirmed the IPO is in the works.
  • This move could offer direct investment opportunities in a leading AI firm.

Wealth-Impact Simulator

See what a one-time investment could grow to.

Amount invested₹1,00,000
Holding period10 yrs
Expected return (p.a.)12%
Future value
₹3,10,585
Potential gain
₹2,10,585

Indicative estimate for education only — not investment advice.

Explore investments
Remind Me Radar
Remind me before this IPO closes
Recommended for you
Track live & upcoming IPOs
View IPO Center
Listen to this article
AI voice · Podcast mode
Get IPO & market alerts free on Telegram / WhatsApp
AI Summary

Artificial intelligence leader OpenAI is targeting an Initial Public Offering (IPO) within the next three years, according to its Chief Financial Officer (CFO). The company is reportedly preparing for this significant financial milestone, which could offer investors a chance to buy into one of the world's most prominent AI firms.

Key Highlights
  • OpenAI is planning to go public with an IPO, potentially by 2027.
  • The company's CFO has confirmed the IPO is in the works.
  • This move could offer direct investment opportunities in a leading AI firm.
  • The AI sector is seeing significant investor interest.
Key Takeaways
  • OpenAI is planning to go public with an IPO, potentially by 2027.
  • The company's CFO has confirmed the IPO is in the works.
  • This move could offer direct investment opportunities in a leading AI firm.
  • The AI sector is seeing significant investor interest.

OpenAI, the company behind advanced AI models like ChatGPT, is gearing up for a public listing, with its Chief Financial Officer (CFO) indicating that an Initial Public Offering (IPO) is anticipated around 2027, or potentially sooner. This announcement signals a major step for the artificial intelligence powerhouse as it looks towards becoming a publicly traded entity.

Preparing for Public Markets

While specific details regarding the IPO's size, valuation, or exact timing remain undisclosed, the CFO's statement suggests that internal preparations are underway. Companies typically undertake extensive financial audits, regulatory compliance checks, and strategic planning in the years leading up to an IPO. For OpenAI, this phase involves solidifying its business model and demonstrating consistent growth potential to attract public market investors.

What This Means for Investors

An IPO would allow retail and institutional investors to purchase shares in OpenAI, offering a direct investment opportunity in the rapidly expanding AI sector. Currently, access to OpenAI's growth has been primarily through private investments or partnerships, such as its significant collaboration with Microsoft. A public listing would democratize this access, though the exact share price and availability for Indian retail investors would depend on the listing venue and regulatory frameworks.

The AI Landscape and IPOs

The prospect of an OpenAI IPO comes at a time when artificial intelligence is a dominant theme in global markets. Several AI-focused companies have seen substantial growth, and investors are keenly looking for opportunities to capitalize on this trend. OpenAI's potential listing could set a new benchmark for AI company valuations and influence future investment strategies in the technology sector.

The company's trajectory will be closely watched, especially its ability to translate its technological advancements into sustainable revenue streams and profitability, key factors that public market investors scrutinize.

This is an informational report and not investment advice.

Community Pulse · This story

How readers rate the outlook after reading this article. Anonymous · one vote per reader · updates live.

Bullish 50%50% Bearish
Be the first to call it
Did this advice help you?
Recommended for you
Products related to this story — compare & act
Smart picks
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
17.4%
3Y CAGR
Bharat Mobility IPO
Mainboard · Auto
+20.5%
GMP
View IPO
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
14.4%
3Y CAGR
GreenVolt Energy IPO
Mainboard · Renewables
+13.8%
GMP
View IPO
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
14.2%
3Y CAGR
HDFC Balanced Advantage Fund
HDFC Mutual Fund · Hybrid
13.2%
3Y CAGR

IPO investments are subject to market risk and allotment. Read the RHP / prospectus before applying; grey-market premium (GMP) is unofficial and unreliable. Some listings may be sponsored. Not investment advice.

Frequently Asked Questions

When is OpenAI planning to go public?

OpenAI's CFO has indicated that the company is targeting an Initial Public Offering (IPO) around 2027, or possibly sooner.

What does an IPO mean for investors?

An IPO allows the general public, including retail investors, to buy shares of a company, providing a direct way to invest in its growth.

Is OpenAI a profitable company?

The source material does not provide details on OpenAI's current profitability, but investors will closely examine its revenue streams and growth potential ahead of its IPO.

Stay ahead of the market

Join the Arth Vani channels

Daily news summaries, IPO & market alerts on Telegram and WhatsApp.

Related Stories

Madhur Knit Crafts, ABH Healthcare SME IPOs Open; Madhur Knit Sees 16% GMP
IPOBreaking
IPOs

Madhur Knit Crafts, ABH Healthcare SME IPOs Open; Madhur Knit Sees 16% GMP

The SME IPOs for Madhur Knit Crafts and ABH Healthcare opened on August 24, 2026, attracting initial investor interest. Madhur Knit Crafts is currently showing a Grey Market Premium (GMP) of 16%, while ABH Healthcare has no GMP reported. Both IPOs will close on August 27, 2026, with listings anticipated by September 1, 2026.

6h ago·2 min readListen
Avaada Electro Plans $800 Million IPO to Expand Solar Manufacturing Capacity
IPOBreaking
IPOs

Avaada Electro Plans $800 Million IPO to Expand Solar Manufacturing Capacity

Solar energy player Avaada Electro is preparing for an initial public offering (IPO) to raise approximately $800 million (₹6,700 crore). The company has reportedly engaged investment banks for a share sale that will include both fresh equity and an offer for sale from existing investors.

6h ago·1 min readListen
Indian Primary Market Heats Up: 10 IPOs to Raise Over ₹3,500 Crore This Week
IPOBreaking
IPOs

Indian Primary Market Heats Up: 10 IPOs to Raise Over ₹3,500 Crore This Week

The Indian stock market is set for a busy week with 10 initial public offerings (IPOs) hitting the primary market to raise over ₹3,500 crore. The lineup includes six mainboard issues and four SME offerings, led by the significant Symbiotec Pharmalab IPO.

12h ago·1 min readListen
Symbiotec Pharmalab Plans ₹150 Crore IPO for Debt Repayment, Expansion
IPOBreaking
IPOs

Symbiotec Pharmalab Plans ₹150 Crore IPO for Debt Repayment, Expansion

Symbiotec Pharmalab, a global leader in corticosteroid and steroidal-hormone APIs, is planning an Initial Public Offering (IPO) to raise ₹150 crore. The funds are earmarked for repaying existing debt and expanding its operational capabilities. The company has shown consistent revenue and EBITDA growth, primarily driven by its international market presence, particularly in Europe.

12h ago·1 min readListen